Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Saeki

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay]S Takagami, M Nishiyama, R Kim, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation]K Sakai, H Nomura, T Nogami, et al.
Arthritis and Rheumatism|October 1, 1996
High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosisH Hasegawa, S Nishi, S Ito, et al.
Gut|August 13, 2003
Endogenous prostaglandin I2 regulates the neural emergency system through release of calcitonin gene related peptideK Arai, T Ohno, T Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Evidence for Taxotere treatment with solid tumors]T Saeki, S Takashima, Y Sasaki, et al.
Gastroenterology|February 24, 2001
Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nervesK Boku, T Ohno, T Saeki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788K Ishikawa, M Ihara, K Noguchi, et al.
The Japanese Journal of Surgery|July 1, 1989
The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/proteinM Nishiyama, M Hirono, S Takagami, et al.
Life Sciences|January 1, 1992
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorM Ihara, K Noguchi, T Saeki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumorsT Kurata, Y Shimada, T Tamura, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay]S Takagami, M Nishiyama, R Kim, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation]K Sakai, H Nomura, T Nogami, et al.
Arthritis and Rheumatism|October 1, 1996
High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosisH Hasegawa, S Nishi, S Ito, et al.
Gut|August 13, 2003
Endogenous prostaglandin I2 regulates the neural emergency system through release of calcitonin gene related peptideK Arai, T Ohno, T Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Evidence for Taxotere treatment with solid tumors]T Saeki, S Takashima, Y Sasaki, et al.
Gastroenterology|February 24, 2001
Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nervesK Boku, T Ohno, T Saeki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788K Ishikawa, M Ihara, K Noguchi, et al.
The Japanese Journal of Surgery|July 1, 1989
The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/proteinM Nishiyama, M Hirono, S Takagami, et al.
Life Sciences|January 1, 1992
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorM Ihara, K Noguchi, T Saeki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumorsT Kurata, Y Shimada, T Tamura, et al.
Pageof 25